Mérieux Equity Partners (MxEP)

Mérieux Equity Partners (MxEP) is a specialized French investment firm focused on the healthcare and nutrition sectors. Operating under the accreditation of the French financial markets authority (AMF), the firm draws on the legacy and global network of Institut Mérieux. With offices in Lyon and Paris, MxEP leverages its deep sector expertise to support businesses that aim to transform healthcare outcomes and drive sustainable development in life sciences. The firm's portfolio spans a wide array of health-related solutions, including diagnostics, therapeutics, medtech, and food safety.

The firm's investment strategy is structured around two main platforms: Venture and Buyout. The Venture arm targets early-stage companies developing innovative medical technologies and life science tools, while the Buyout arm focuses on mature, profitable, and fast-growing European businesses. MxEP provides both majority and minority stakes, offering strategic and financial guidance throughout each company’s growth lifecycle. This dual approach allows MxEP to remain active across multiple stages of corporate development, from innovation to industrial scale.

With a team of 24 full-time professionals and 6 seasoned senior advisors, MxEP combines operational know-how with financial rigor. The firm actively incorporates ESG criteria into its investment philosophy and advocates a "One Health" perspective — a holistic view linking human, animal, and environmental health. MxEP has managed over €1.5 billion in assets and backed more than 50 companies, primarily in Europe and selectively in North America, positioning itself as a long-term partner in building the next generation of health leaders.